Publications by authors named "C Gedye"

Claim this Profile
F
First-line Pembrolizumab Plus Lenvatinib for Advanced Non-clear-cell Renal Cell Carcinoma: Updated Results from the Phase 2 KEYNOTE-B61 Trial.
Martin H Voss, Howard Gurney, Vagif Atduev, Cristina Suarez, Miguel A Climent, Craig Gedye

Eur Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel Study.
Andrew J Armstrong, Fred Saad, Mototsugu Oya, Karina Vianna, Mustafa Özgüroğlu, Craig Gedye

Eur Urol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
and derived macrophages occupy distinct phenotypic states.
Stéphane Chevrier, Vito R T Zanotelli, Daniel Schulz, Mark D Robinson, Laurie Ailles, Craig Gedye

bioRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of nivolumab plus ipilimumab: Infusion of the fixed-ratio combination versus sequential infusions in two randomized controlled trials of metastatic melanoma (CheckMate 742) and renal cell carcinoma (CheckMate 800).
Alexander M Menzies, Pamela Salman, Osvaldo Arén Frontera, David Pook, Christopher M Hocking, Craig Gedye

Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to Support Participants in Urogenital and Prostate Clinical Trials: A Qualitative Perspective.
Natasha A Roberts, Ian D Davis, David Wyld, Jeffrey Goh, Maxwell Thompson, Craig Gedye

Psychooncology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis